Updated February 2026
D-Limonene and proton pump inhibitors (PPIs) are two fundamentally different approaches to managing acid reflux and GERD — one is a citrus-derived natural compound that works by coating the esophagus, while the other is a pharmaceutical drug class that suppresses stomach acid production. With an estimated 20–30% of American adults experiencing GERD symptoms and over 15 million PPI prescriptions written annually, understanding the differences between these options is critical for making informed treatment decisions.
Orange Burps is a D-Limonene-based dietary supplement designed to support digestive health and provide natural relief from heartburn and acid reflux symptoms.
What Are PPIs and How Do They Work?
Proton pump inhibitors (PPIs) are a class of medications that reduce stomach acid production by irreversibly blocking the hydrogen-potassium ATPase enzyme system — the “proton pump” — on the surface of gastric parietal cells. Common PPIs include omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid), and pantoprazole (Protonix).
PPIs are among the most widely prescribed medications in the United States. Approximately 10% of Americans use PPIs, and omeprazole ranks among the top 10 most prescribed drugs nationally. Americans spend more than $10 billion per year on PPIs. The FDA advises that over-the-counter PPIs should be used for no more than three 14-day treatment courses over one year, yet epidemiologic studies show that 60% of patients using PPIs do not have definitive indications for their use.
What Is D-Limonene and How Does It Work?
D-Limonene is a monocyclic monoterpene naturally found in the peel of citrus fruits, particularly oranges. The FDA classifies D-Limonene as “Generally Recognized As Safe” (GRAS) as a food flavoring agent, and it appears in everyday products like fruit juices, soft drinks, baked goods, and ice cream.
Unlike PPIs, D-Limonene does not suppress stomach acid production. Instead, it works through several complementary mechanisms:
- Esophageal coating: Because D-Limonene (orange oil) is lighter than water, it floats on top of gastric juices. When released through a burp, it coats the esophageal lining, creating a protective barrier against caustic stomach contents.
- Increased mucus production: A 2019 animal study demonstrated that D-Limonene increases mucus production and maintains basal prostaglandin E2 (PGE2) levels, strengthening the mucosal defense system without affecting acid secretion or serum gastrin levels.
- Peristalsis support: D-Limonene may stimulate faster gastric emptying, reducing the volume of gastric acid, bile, and pepsin available to reflux upward into the esophagus.
- Antimicrobial activity: D-Limonene may inhibit Gram-negative bacterial overgrowth, including H. pylori, potentially reducing inflammation in the duodenum, stomach, and esophagus.
Clinical Evidence: D-Limonene for Acid Reflux
The primary clinical evidence for D-Limonene comes from two studies conducted by researchers who developed the original supplementation protocol:
Pilot Study (19 Patients)
In the initial pilot study, 19 patients with chronic heartburn or GERD (all experiencing symptoms for at least five years, ranging from mild to severe) were given 1000 mg of D-Limonene daily or every other day. After 14 days, 89% of patients reported complete remission of symptoms.
Randomized Follow-Up Study (13 Participants)
A follow-up randomized study enrolled 13 participants with GERD or chronic heartburn. Participants received either 1000 mg D-Limonene once daily, 1000 mg every other day, or placebo. Results showed that 29% experienced significant relief by day 4, and 86% achieved complete relief of all symptoms by day 14.
Limitations of the Evidence
It is important to note that the existing D-Limonene research has limitations. The pilot study lacked a placebo group and had a small sample size. Both studies used heterogeneous dosing patterns and differently standardized extracts (98.5–99.3% vs. 98% purity). A 2017 review highlighted that larger, high-quality randomized controlled trials are needed to confirm D-Limonene’s efficacy for GERD. However, the preliminary results are promising and warrant further investigation.
Clinical Evidence: PPIs for Acid Reflux
PPIs have a much larger body of clinical evidence supporting their short-term efficacy. They are considered the most potent acid-suppressing medications available and are effective for treating erosive esophagitis, healing peptic ulcers, and managing GERD symptoms. Most patients experience significant symptom improvement within 1–2 weeks of starting PPI therapy.
However, roughly half of PPI users report persistent symptoms despite treatment, according to research published in Gastroenterology. This raises important questions about whether acid suppression alone addresses the underlying causes of reflux in all patients.
Risks of Long-Term PPI Use: What the Research Shows
While PPIs are effective for short-term acid suppression, a growing body of research has raised concerns about long-term use. According to a 2025 systematic review published in Cureus, the following risks have been associated with chronic PPI use:
Kidney Disease
PPI users face a 50% higher risk of chronic kidney disease (CKD) and a 35% elevated risk of end-stage renal disease, according to multiple observational studies. More than half of patients who develop chronic kidney damage while taking PPIs experience no acute kidney problems beforehand, meaning renal function may silently deteriorate. A 2024 systematic review and meta-analysis published in Biomedicines investigated this relationship and found proposed mechanisms including alterations in gut microbiota, nutrient malabsorption, and toxic effects on renal tubular cells.
Bone Fractures
The FDA has issued warnings about increased fracture risk with PPIs. Studies show PPI users have a 33% higher relative risk for fractures at any site, with spine fractures specifically showing a 58% increased risk. Hip fracture risk data remains inconsistent across studies, but the overall pattern suggests a dose-dependent and duration-dependent relationship.
Gut Infections
PPIs are strongly associated with Clostridioides difficile infection (CDI). The FDA has issued safety warnings, and a 2025 umbrella review found pooled odds ratios of approximately 1.3–2.3 for CDI risk among PPI users. Reduced stomach acid allows pathogenic bacteria to survive passage through the stomach.
Nutrient Deficiencies
Long-term acid suppression can impair absorption of critical nutrients including magnesium, vitamin B12, calcium, and iron. These deficiencies may contribute to other complications like osteoporosis and neurological symptoms over time.
Dementia
Observational studies, particularly in Asian populations, have linked PPI use to a 22% higher dementia risk. One study found that PPI use for greater than 4.4 years in individuals aged 45 and older was associated with higher incidence of newly diagnosed dementia. However, a 2024 Mendelian randomization study found no robust causal link, suggesting earlier associations may have been influenced by confounding factors.
Rebound Acid Hypersecretion
Perhaps the most concerning issue with PPIs is what happens when you try to stop taking them. A landmark 2009 randomized, double-blind, placebo-controlled trial published in Gastroenterology (Reimer et al.) studied 120 healthy volunteers. After 8 weeks of esomeprazole 40 mg daily followed by 4 weeks of placebo, 44% of those in the PPI group developed acid-related symptoms — compared to just 15% in the placebo group (P < .001).
This happens because long-term acid suppression triggers a compensatory increase in the hormone gastrin. When the PPI is withdrawn, this elevated gastrin drives excess acid production — often worse than before treatment began. This rebound effect can trap patients in a cycle of PPI dependency, as they mistakenly believe their original condition has returned.
D-Limonene vs. PPIs: Side-by-Side Comparison
| Factor | D-Limonene | PPIs |
|---|---|---|
| How it works | Coats esophagus, increases mucus, supports peristalsis | Blocks stomach acid production |
| Onset of relief | 29% by day 4; 86–89% by day 14 | Significant improvement within 1–2 weeks |
| Typical dosage | 1000 mg daily or every other day for 14–20 days | 20–40 mg daily, ongoing |
| Treatment duration | 14–20 day course; then as needed | Often prescribed indefinitely |
| Stomach acid levels | Preserved — does not suppress acid | Significantly reduced |
| FDA status | GRAS (Generally Recognized As Safe) | FDA-approved prescription/OTC drug |
| Rebound effect | Not reported | 44% experience rebound symptoms after stopping |
| Long-term safety concerns | Low toxicity demonstrated up to 1 year | Kidney disease, fractures, infections, nutrient deficiencies |
| Clinical evidence quality | Preliminary (small studies, promising results) | Extensive (large RCTs, meta-analyses) |
| Approximate monthly cost | $20–$30 | $10–$50+ (varies by brand/insurance) |
Who Might Benefit from D-Limonene vs. PPIs?
The choice between D-Limonene and PPIs depends on the severity of your condition, your treatment goals, and your tolerance for risk.
D-Limonene May Be a Good Fit If You:
- Have mild to moderate heartburn or GERD symptoms
- Want to preserve normal stomach acid levels for healthy digestion
- Are concerned about long-term side effects of acid-suppressing drugs
- Are trying to wean off PPIs and need transitional support
- Prefer a short-course treatment (14–20 days) over daily indefinite medication
- Want a supplement with a strong safety profile and GRAS designation
PPIs May Be More Appropriate If You:
- Have severe erosive esophagitis or Barrett’s esophagus
- Need short-term healing of peptic ulcers
- Have been diagnosed with conditions that require aggressive acid suppression
- Are under the care of a gastroenterologist who recommends them
Important: Always consult your healthcare provider before starting, stopping, or switching any treatment for acid reflux or GERD. This article is for informational purposes and does not constitute medical advice.
Can You Use D-Limonene to Help Transition Off PPIs?
Some practitioners suggest D-Limonene as a supportive option when tapering off PPIs. Because D-Limonene coats and protects the esophagus without suppressing acid production, it may help manage symptoms during the rebound acid hypersecretion phase that occurs when PPIs are reduced or discontinued.
A typical approach involves gradually reducing the PPI dose over several weeks while introducing D-Limonene (1000 mg every other day) to provide esophageal protection. However, this strategy should always be discussed with a healthcare provider, as abrupt PPI discontinuation can cause significant rebound symptoms.
The Bottom Line: D-Limonene vs. PPIs
PPIs are powerful acid-suppressing drugs with strong clinical evidence for short-term use. However, the growing body of research on long-term risks — including kidney disease, bone fractures, gut infections, and rebound acid hypersecretion — has led organizations like the American Gastroenterological Association to emphasize appropriate PPI usage and deprescribing when possible.
D-Limonene represents a fundamentally different approach: protecting the esophagus and supporting digestive function without suppressing the stomach acid your body needs for digestion, nutrient absorption, and pathogen defense. While larger clinical trials are needed, the existing evidence shows promising symptom relief with a strong safety profile.
For many people with mild to moderate acid reflux, D-Limonene offers a compelling natural alternative — or complement — to conventional acid-suppressing medications. Orange Burps delivers 1000 mg of pharmaceutical-grade D-Limonene per softgel, matching the dosage used in clinical studies.
Frequently Asked Questions
Is D-Limonene as effective as PPIs for acid reflux?
In small clinical studies, 1000 mg of D-Limonene taken daily or every other day for 14 days produced complete symptom relief in 86–89% of participants with chronic heartburn or GERD. PPIs also show high efficacy rates in larger studies. The key difference is that D-Limonene protects the esophagus without suppressing stomach acid, while PPIs work by blocking acid production entirely. Larger head-to-head trials are needed for definitive comparison.
What are the side effects of D-Limonene compared to PPIs?
D-Limonene has demonstrated low toxicity in humans after single and repeated dosing for up to one year and carries FDA GRAS status. Possible side effects include mild gastrointestinal discomfort at high doses (above 8 grams per day). PPIs, while generally well tolerated short-term, have been linked to kidney disease (50% higher CKD risk), bone fractures (33% higher risk), C. difficile infections, nutrient deficiencies, and rebound acid hypersecretion upon discontinuation.
Can I take D-Limonene while on PPIs?
D-Limonene is metabolized by cytochrome P450 enzymes, which also metabolize many medications including some PPIs like omeprazole. If you are currently taking PPIs and want to try D-Limonene, consult your healthcare provider to discuss potential interactions and develop a safe transition plan.
How long does it take for D-Limonene to work for heartburn?
In clinical studies, 29% of participants experienced significant relief by day 4 of taking 1000 mg D-Limonene, and 86% achieved complete symptom relief by day 14. The standard protocol involves taking one 1000 mg softgel daily or every other day for 14–20 days, followed by use as needed for occasional relief.
Why does acid reflux come back after stopping PPIs?
Long-term PPI use causes the body to increase production of the hormone gastrin to compensate for suppressed acid levels. When the PPI is stopped, this excess gastrin drives a surge in acid production called rebound acid hypersecretion (RAHS). A 2009 study in Gastroenterology found that 44% of healthy volunteers developed acid-related symptoms after stopping 8 weeks of PPI therapy. This can create a cycle of dependency where patients restart PPIs believing their original condition has worsened.
Related guide: Best Natural Remedies for GERD: Evidence-Based Options Ranked — See how D-Limonene compares to other natural alternatives like alginates, melatonin, and DGL licorice.
